SDOS Stock Overview
Engages in the provision of measurement systems and software designed for the QA and validation of new dynamic and modulated treatments implemented in clinics worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
ScandiDos AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.59 |
| 52 Week High | SEK 2.75 |
| 52 Week Low | SEK 1.48 |
| Beta | 1.17 |
| 11 Month Change | -11.67% |
| 3 Month Change | -4.22% |
| 1 Year Change | -37.89% |
| 33 Year Change | -59.75% |
| 5 Year Change | -54.64% |
| Change since IPO | -90.25% |
Recent News & Updates
Recent updates
A Look At The Intrinsic Value Of ScandiDos AB (publ) (STO:SDOS)
Sep 24
At kr2.77, Is It Time To Put ScandiDos AB (publ) (STO:SDOS) On Your Watch List?
Mar 02Is There Now An Opportunity In ScandiDos AB (publ) (STO:SDOS)?
Sep 18Estimating The Intrinsic Value Of ScandiDos AB (publ) (STO:SDOS)
Nov 17At kr3.19, Is ScandiDos AB (publ) (STO:SDOS) Worth Looking At Closely?
Sep 29ScandiDos AB (publ)'s (STO:SDOS) Shift From Loss To Profit
Jan 12
Shareholder Returns
| SDOS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 4.6% | -0.06% | -1.0% |
| 1Y | -37.9% | -1.1% | 13.3% |
Return vs Industry: SDOS underperformed the Swedish Medical Equipment industry which returned -1.1% over the past year.
Return vs Market: SDOS underperformed the Swedish Market which returned 13.3% over the past year.
Price Volatility
| SDOS volatility | |
|---|---|
| SDOS Average Weekly Movement | 8.2% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.3% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: SDOS has not had significant price volatility in the past 3 months.
Volatility Over Time: SDOS's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 28 | Carl Piehl | scandidos.com |
ScandiDos AB (publ) engages in the provision of measurement systems and software designed for the QA and validation of new dynamic and modulated treatments implemented in clinics worldwide. It offers Delta4 Discover and Delta4 Phantom+ for the QA of advanced radiation therapy procedures such as VMAT, RapidArc, IMRT, and Tomotherapy. The company was incorporated in 2001 and is headquartered in Uppsala, Sweden.
ScandiDos AB (publ) Fundamentals Summary
| SDOS fundamental statistics | |
|---|---|
| Market cap | SEK 72.52m |
| Earnings (TTM) | -SEK 14.65m |
| Revenue (TTM) | SEK 62.54m |
1.2x
P/S Ratio-5.0x
P/E RatioIs SDOS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SDOS income statement (TTM) | |
|---|---|
| Revenue | SEK 62.54m |
| Cost of Revenue | SEK 14.99m |
| Gross Profit | SEK 47.56m |
| Other Expenses | SEK 62.20m |
| Earnings | -SEK 14.65m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 76.03% |
| Net Profit Margin | -23.42% |
| Debt/Equity Ratio | 0% |
How did SDOS perform over the long term?
See historical performance and comparison